Iris Melanoma Arising in Iris Nevus in Oculo(dermal) Melanocytosis

Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.
Survey of Ophthalmology (Impact Factor: 3.85). 07/2008; 53(4):411-5. DOI: 10.1016/j.survophthal.2008.04.004
Source: PubMed


A 50-year-old white man with oculo(dermal) melanocytosis and longstanding iris nevus was found to have growth of the iris mass. Excision and histopathologic examination revealed a mixed cell type malignant melanoma. Benign nevus cells were present at the periphery of the tumor surrounding the entire melanoma. White patients with oculo(dermal) melanocytosis have a predisposition to uveal melanoma, which is usually choroidal in origin. Literature review showed only three confirmed cases of iris melanoma in this setting. Two additional cases initially published as spindle A melanoma have been reclassified as iris nevi based on the modified Callender classification of uveal melanomas. It is recommended that patients with oculo(dermal) melanocytosis be followed for the occurrence of uveal melanoma.

1 Read
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To report a clinicopathologic correlation of a melanoma arising from iris component of ocular melanocytosis in a child. A 13-year-old boy developed a progressive iris nodule arising from sector iris pigmentation that was a component of congenital ocular melanocytosis involving the iris, ciliary body and choroid. The tumor was examined clinically and with ultrasound biomicroscopy (UBM), removed by peripheral iridocyclectomy, and studied histopathologically. Clinically, the pigmented nodule was 3 mm in diameter, located within the sector iris pigmentation, and was 2.4 mm in thickness as measured by UBM. Histopathologically, it was composed predominately of spindle B melanoma cells with adjacent spindle and dendritic melanocytes compatible with iris melanocytosis. Although highly unusual, melanoma can arise in the sector iris pigmentation that is often a component of congenital ocular melanocytosis. Even young patients with ocular melanocytosis should be examined periodically for development of melanoma in the ciliary body and choroid.
    Cornea 09/2009; 28(10):1191-3. DOI:10.1097/ICO.0b013e31819b3384 · 2.04 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Das Aderhautmelanom ist ein seltener sporadischer Tumor mit einer hohen Mortalitätsrate. Trotz aller Fortschritte in der Behandlung des Tumors hat sich die Überlebensrate der PatientInnen seit Jahrzehnten nicht verbessert. Die Erforschung der Grundlagen der Entstehung und Metastasierung des Aderhautmelanoms hat in den letzten Jahren rasche Fortschritte gezeigt. Das verbesserte Verständnis der genetischen und molekularen Grundlagen dieses Tumors zeigt nun erste Auswirkungen auf die klinische Praxis, und es besteht Hoffnung auf die Entwicklung verbesserter Therapien und eine verbesserte Überlebensprognose. Die vorliegende Arbeit gibt einen Überblick über die klinische Genetik, die Zytogenetik und die Molekulargenetik des Aderhautmelanoms, schildert neuere Forschungsergebnisse in diesen Teilbereichen und beschreibt die Auswirkungen in der Betreuung ophthalmo-onkologischer Patienten. Uveal melanoma is a rare sporadic tumor with high mortality. Despite all advances in the treatment of this malignancy, mortality rate has not improved over the past decades. Tremendous advances in research on the development of uveal melanoma and metastatic disease have changed our understanding of this disease over the past years. New insights into the genetic and molecular fundamentals of uveal melanoma show first impacts in the clinical management of affected patients, and there is reason for hope, that the development of new treatments will improve the still poor prognosis. The objective of this work is to provide an overview on our current understanding of clinical genetics, cyto- and molecular genetics, to explain recent research in this field and to describe how recent findings have already begun to change the treatment of uveal melanoma patients. SchlüsselwörterAderhautmelanom-Genetik-Zytogenetik-Molekulargenetik-Prognose KeywordsUveal melanoma-Clinical genetics-Cytogenetics-Molecular genetics-Prognosis
    Spektrum der Augenheilkunde 11/2009; 23(5):319-332. DOI:10.1007/s00717-009-0360-7 · 0.18 Impact Factor
  • Source
    Chinese medical journal 01/2010; 123(1):111-3. DOI:10.3760/cma.j.issn.0366-6999.2010.01.021 · 1.05 Impact Factor
Show more